CRYO-CELL INTERNATIONAL, INC. (CCEL) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-05-31..
Operating margin
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -103.78K USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | 6.87M USD | Cost of Goods and Services Sold |
| Research and development | 311.95K USD | Research and Development Expense |
| Selling, general and administration | 18.95M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-05-31 | $-103.78K | (m) | $6.87M | $311.95K | $18.95M | (m) |
| 2026-02-28 | $191.52K | (m) | $7.05M | $343.88K | $18.59M | (m) |
| 2025-11-30 | $482.39K | (m) | $7.38M | $376.26K | $18.22M | (m) |
| 2025-08-31 | $4.33M | (m) | $7.28M | $596.11K | $18.78M | (m) |
| 2025-05-31 | $3.82M | (m) | $7.60M | $728.42K | $19.07M | (m) |
| 2025-02-28 | $3.72M | (m) | $7.87M | $837.79K | $18.73M | (m) |
| 2024-11-30 | $3.48M | (m) | $7.95M | $1.24M | $18.52M | (m) |
| 2024-08-31 | $-12.57M | (m) | $8.39M | $1.38M | $17.90M | (m) |
| 2024-05-31 | $-12.80M | (m) | $8.42M | $1.53M | $17.56M | (m) |
| 2024-02-29 | $-13.17M | (m) | $8.54M | $1.60M | $17.58M | (m) |
| 2023-11-30 | $-12.30M | (m) | $8.44M | $1.17M | $17.12M | (m) |
| 2023-08-31 | $4.28M | (m) | $8.51M | $804.05K | $16.41M | (m) |
| 2023-05-31 | $4.07M | (m) | $8.70M | $540.19K | $16.21M | (m) |
| 2023-02-28 | $4.24M | (m) | $8.76M | $316.40K | $16.08M | (m) |
| 2022-11-30 | $4.02M | (m) | $8.79M | $384.79K | $15.58M | (m) |
| 2022-08-31 | $2.80M | (m) | $8.95M | $338.83K | $15.44M | (m) |
| 2022-05-31 | $3.44M | (m) | $9.06M | $268.56K | $15.33M | (m) |
| 2022-02-28 | $4.24M | (m) | $9.08M | $190.90K | $14.57M | (m) |
| 2021-11-30 | $4.00M | (m) | $8.99M | $49.87K | $14.63M | (m) |
| 2021-08-31 | $7.01M | (m) | $9.01M | $26.49K | $13.57M | (m) |
| 2021-05-31 | $7.89M | (m) | $8.91M | $17.73K | $13.45M | (m) |
| 2021-02-28 | $7.65M | (m) | $9.17M | $24.32K | $13.86M | (m) |
| 2020-11-30 | $7.66M | (m) | $9.66M | $23.85K | $14.29M | (m) |
| 2020-08-31 | $7.20M | (m) | $9.70M | $33.66K | $14.75M | (m) |
| 2020-05-31 | $6.71M | (m) | $9.93M | $34.85K | $14.93M | (m) |
| 2020-02-29 | $5.46M | (m) | $10.07M | $29.98K | $15.02M | (m) |
| 2019-11-30 | $5.06M | (m) | $10.04M | $30.14K | $14.89M | (m) |
| 2019-08-31 | $5.48M | (m) | $10.36M | $40.20K | $15.07M | (m) |
| 2019-05-31 | $4.40M | (m) | $10.26M | $59.99K | $15.90M | (m) |
| 2019-02-28 | $5.06M | (m) | $9.40M | $84.32K | $15.79M | (m) |
| 2018-11-30 | $5.19M | (m) | $8.54M | $91.84K | $15.63M | (m) |
| 2018-08-31 | $4.30M | (m) | (m) | $82.41K | $15.05M | (m) |
| 2018-05-31 | $4.83M | $26.12M | (m) | $60.40K | $14.09M | 18.51% |
| 2018-02-28 | $4.88M | $25.84M | (m) | $39.96K | $13.97M | 18.88% |
| 2017-11-30 | $5.01M | $25.38M | (m) | $41.16K | $13.48M | 19.72% |
| 2017-08-31 | $4.22M | $24.78M | (m) | $42.33K | $13.75M | 17.02% |
| 2017-05-31 | $1.70M | $24.22M | (m) | $55.88K | $14.23M | 7.03% |
| 2017-02-28 | $1.39M | $23.75M | (m) | $59.03K | $14.22M | 5.87% |
| 2016-11-30 | $433.59K | $23.13M | (m) | $53.10K | $14.72M | 1.87% |
| 2016-08-31 | $418.36K | $23.06M | (m) | $47.76K | $14.75M | 1.81% |
| 2016-05-31 | $2.74M | $22.16M | (m) | $43.93K | $13.47M | 12.39% |
| 2016-02-29 | $2.46M | $21.40M | (m) | $42.48K | $13.07M | 11.52% |
| 2015-11-30 | $2.93M | $21.09M | (m) | $45.78K | $12.39M | 13.91% |
| 2015-08-31 | $2.68M | $20.27M | (m) | $46.30K | $11.98M | 13.21% |
| 2015-05-31 | $1.84M | $19.77M | (m) | $54.20K | $12.30M | 9.32% |
| 2015-02-28 | $1.80M | $19.65M | (m) | $61.99K | $12.04M | 9.17% |
| 2014-11-30 | $1.98M | $20.13M | (m) | $64.37K | $12.25M | 9.84% |
| 2014-08-31 | $2.26M | $19.86M | (m) | $60.59K | $11.70M | 11.40% |
| 2014-05-31 | $2.42M | $19.75M | (m) | $50.87K | $11.59M | 12.24% |
| 2014-02-28 | $1.94M | $19.72M | (m) | $39.62K | $11.79M | 9.86% |
| 2013-11-30 | $1.70M | $18.99M | (m) | $36.17K | $11.37M | 8.96% |
| 2013-08-31 | $686.52K | $19.11M | (m) | $47.30K | $12.41M | 3.59% |
| 2013-05-31 | $142.43K | $18.82M | (m) | $105.21K | $12.63M | 0.76% |
| 2013-02-28 | $-1.07M | $18.39M | (m) | $105.98K | $13.96M | -5.81% |
| 2012-11-30 | $-1.71M | $17.97M | (m) | $109.64K | $14.43M | -9.52% |
| 2012-08-31 | $-853.09K | $17.58M | (m) | $104.00K | $12.74M | -4.85% |
| 2012-05-31 | $-2.79M | $17.45M | (m) | $90.19K | $14.64M | -16.01% |
| 2012-02-29 | $-1.04M | $17.62M | (m) | $163.00K | $13.06M | -5.91% |
| 2011-11-30 | $-276.74K | $17.92M | (m) | $184.05K | $12.41M | -1.54% |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-02-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-11-30 | $3.35M | $17.76M | (m) | $132.99K | $9.49M | 18.83% |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |